A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] …
Category: Providers
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The growth in total 340B purchases last year was largely a result of drugmaker price increases and broader healthcare trends, [...] …